Edina, B. C., & Rinaldi, I. (2022). Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin’s Lymphoma or Mantle-Cell Lymphoma. Acta Medica Indonesiana, 54(2), 316. Retrieved from https://actamedindones.org/index.php/ijim/article/view/1584